Dian Swastatika Sentosa Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Dian Swastatika Sentosa Tbk trades at Rp990 (market cap 192.64T, 655.02M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Dian Swastatika Sentosa Tbk is far larger — about 302.9× UBC Medical Indonesia Tbk.'s market cap, and Dian Swastatika Sentosa Tbk is more actively traded (655.02M versus 843K). Which is the better fit depends on your goals.
| DSSA | LABS | |
|---|---|---|
Market Cap | 192.64T | 635.95B |
Volume | 655.02M | 843K |
Lot | 6.55M | 8.43K |
Turnover | 649.58B | 137.6M |
Average Price | 991.7 | 163.22 |
Value | 649.58B | 137.6M |
Indicative Equilibrium Price | 990 | 165 |
Indicative Equilibrium Volume | 73.9K | 246 |
Trailing returns across standard periods
Latest headlines on both assets
PT Dian Swastatika Sentosa Tbk (the company) was established on August 2, 1996 based on Notarial Deed No. 6 and was amended by Notarial Deed No. 35 dated October 8, 1996, both of Linda Herawati, S.H., a public notary in Jakarta. The Company operates under the Sinarmas group of business.
Read more on DSSA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →